OC
ABBV icon

Oakworth Capital’s AbbVie ABBV Stock Holding History

Oakworth Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
12,650
+1,337
+12% +$288K 0.15% 49
2026
Q1 		$2.46M Buy
11,313
+667
+6% +$148K 0.13% 49
2025
Q4 		$2.43M Buy
10,646
+965
+10% +$220K 0.13% 48
2025
Q3 		$2.24M Buy
9,681
+507
+6% +$103K 0.13% 49
2025
Q2 		$1.7M Sell
9,174
-985
-10% -$183K 0.11% 55
2025
Q1 		$2.13M Sell
10,159
-725
-7% -$141K 0.15% 48
2024
Q4 		$1.93M Sell
10,884
-100
-0.9% -$18.4K 0.13% 51
2024
Q3 		$2.17M Sell
10,984
-2,772
-20% -$517K 0.15% 48
2024
Q2 		$2.36M Sell
13,756
-183
-1% -$30.3K 0.17% 45
2024
Q1 		$2.54M Buy
13,939
+717
+5% +$124K 0.19% 44
2023
Q4 		$2.05M Buy
13,222
+90
+0.7% +$13.1K 0.16% 44
2023
Q3 		$1.96M Sell
13,132
-62
-0.5% -$9.1K 0.18% 42
2023
Q2 		$1.78M Buy
13,194
+33
+0.3% +$4.84K 0.15% 44
2023
Q1 		$2.1M Buy
13,161
+651
+5% +$99.5K 0.19% 40
2022
Q4 		$2.02M Sell
12,510
-500
-4% -$76.7K 0.19% 35
2022
Q3 		$1.75M Sell
13,010
-10
-0.1% -$1.44K 0.19% 38
2022
Q2 		$1.99M Sell
13,020
-45
-0.3% -$6.88K 0.2% 39
2022
Q1 		$2.12M Buy
13,065
+741
+6% +$108K 0.18% 41
2021
Q4 		$1.67M Buy
12,324
+570
+5% +$67.3K 0.14% 51
2021
Q3 		$1.27M Buy
11,754
+290
+3% +$33.1K 0.12% 55
2021
Q2 		$1.29M Buy
11,464
+238
+2% +$26.8K 0.13% 53
2021
Q1 		$1.22M Buy
11,226
+1,218
+12% +$130K 0.14% 54
2020
Q4 		$1.07M Buy
10,008
+216
+2% +$20.8K 0.14% 50
2020
Q3 		$858K Sell
9,792
-52
-0.5% -$4.9K 0.14% 60
2020
Q2 		$967K Sell
9,844
-9
-0.1% -$792 0.17% 48
2020
Q1 		$750K Buy
9,853
+1,727
+21% +$147K 0.18% 53
2019
Q4 		$727K Buy
8,126
+690
+9% +$57.3K 0.13% 67
2019
Q3 		$563K Sell
7,436
-403
-5% -$27.6K 0.11% 74
2019
Q2 		$570K Sell
7,839
-511
-6% -$40.2K 0.11% 83
2019
Q1 		$673K Sell
8,350
-879
-10% -$71.9K 0.14% 71
2018
Q4 		$851K Sell
9,229
-20
-0.2% -$1.76K 0.19% 52
2018
Q3 		$875K Sell
9,249
-12
-0.1% -$1.14K 0.17% 55
2018
Q2 		$858K Hold
9,261
– – 0.18% 51
2018
Q1 		$894K Buy
9,261
+30
+0.3% +$3.3K 0.21% 46
2017
Q4 		$894K Sell
9,231
-2,540
-22% -$239K 0.21% 53
2017
Q3 		$886K Buy
11,771
+678
+6% +$51.6K 0.23% 49
2017
Q2 		$805K Buy
11,093
+50
+0.5% +$3.36K 0.22% 49
2017
Q1 		$720K Buy
11,043
+192
+2% +$12.1K 0.21% 55
2016
Q4 		$660K Buy
10,851
+645
+6% +$39.4K 0.22% 62
2016
Q3 		$644K Sell
10,206
-1,355
-12% -$87.7K 0.22% 61
2016
Q2 		$728K Hold
11,561
– – 0.27% 56
2016
Q1 		$661K Sell
11,561
-180
-2% -$10K 0.26% 60
2015
Q4 		$696K Buy
11,741
+6,056
+107% +$349K 0.29% 58
2015
Q3 		$309K Hold
5,685
– – 0.16% 55
2015
Q2 		$398K Sell
5,685
-6,000
-51% -$392K 0.19% 53
2015
Q1 		$755K Hold
11,685
– – 0.35% 38
2014
Q4 		$765K Buy
11,685
+6,000
+106% +$378K 0.4% 35
2014
Q3 		$314K Hold
5,685
– – 0.18% 51
2014
Q2 		$321K Hold
5,685
– – 0.2% 51
2014
Q1 		$292K Buy
5,685
+4,586
+417% +$232K 0.19% 54
2013
Q4 		$58K Buy
+1,099
New +$54K 0.04% 110

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Oakworth Capital's ABBV Position: Q2 2026 in Review

Oakworth Capital increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $288K and bringing the position to 12,650 shares worth $3.18M. The position accounts for 0.15% of the portfolio, ranked #49.

Oakworth Capital first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oakworth Capital held 12,650 shares of AbbVie worth $3.18M as of Q2 2026.
  • Oakworth Capital bought 1,337 AbbVie shares in Q2 2026, an estimated $288K.
  • AbbVie made up 0.15% of Oakworth Capital's portfolio in Q2 2026, its #49 holding.
  • Oakworth Capital first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.